Skip to main content
Top
Published in: Molecular Diagnosis & Therapy 1/2007

01-01-2007 | Original Research Article

Diagnostic Impact of Molecular Lineage Analysis on Paraffin-Embedded Tissue in Hematolymphoid Neoplasia Reclassified by Current WHO Criteria

Authors: Leonard Hwan Cheong Tan, Lily-Lily Chiu, Evelyn Siew Chuan Koay

Published in: Molecular Diagnosis & Therapy | Issue 1/2007

Login to get access

Abstract

Background and Objective: By current WHO criteria, most — though not all — cases of hematolymphoid neoplasm can be diagnosed immunomorphologically, diminishing the role of molecular tests for lymphoid antigen receptor clonality in lymphoma diagnosis. Hence, our objective was to glean immunomorphological and molecular correlates from hematolymphoid neoplasms that had remained unresolvable without diagnostic molecular input.
Methods: Thirty-five such cases were reviewed histologically and with standard immunoperoxidases. In situ hybridization for Epstein-Barr virus (EBV)-encoded RNAs (EBER) was performed on selected cases. PCR amplification of genes encoding T-cell receptors (TcR) and immunoglobulin heavy chains (IgH) [TR and IGH genes, respectively] was performed on whole tissue in all cases, and on microdissected cells in two cases.
Results: Twenty-five cases (71%) requiring diagnostic molecular genotyping had some form of peripheral T-cell lymphoma (PTCL). Twenty (80%) of these were complicated by a proliferation of B-lineage cells, either within the same tissue (‘syntopic’) as large B cells (LBC) or Reed-Sternberg (RS)-like cells (17 cases), florid lymphoid hyperplasia (two cases, one also with syntopic LBC) or monotypic plasma cells (one case), or at a separate (‘metatopic’) site as a B-cell lymphoma (two cases, one of which also had syntopic LBC) or Hodgkin lymphoma (HL; one case, also showing syntopic LBC). Fifteen (75%) of these 20 PTCLs with B-lineage proliferation yielded monoclonal TR gene rearrangements, and only two (10%) showed IGH monoclonality, which was transient in one case. Three (18%) of the PTCLs with LBC had originally been misinterpreted as some form of HL. Conversely, of the remaining cases, three of four (75%) that had been diagnosed initially as some form of large cell non-HL (NHL), including two of three that were called ‘anaplastic’, had to be revised to grade II/syncytial nodular sclerosing (NS) HL, yielding polyclonal TcRγ gene (TRG) rearrangements, with one case, in addition, disclosing a biallelic clonal IGH gene rearrangement that excluded anaplastic large cell lymphoma.
Discussion/Conclusion: Paradoxically, monoclonality of TR rather than IGH gene rearrangement may more often be detectable in a predominantly dispersed (‘hodgkinoid’), large B-lineage cell proliferation, consistent with release from immune regulation in the milieu of impaired immunosurveillance within a PTCL. This is compounded by the difficulty in ascertaining clonal IGH gene rearrangements resulting from (1) poor consensus primer hybridization due to somatic hypermutations, and (2) ‘dilution’ in a T-cell-rich milieu. These same difficulties also account for the long-elusive identification of the RS cell lineage. Conversely, anaplastic lymphoma, which is of non-B lineage, may be mimicked by NSHL, which is of B lineage.
Appendix
Available only for authorised users
Footnotes
1
Please refer to the table in the supplementary material to this article, which is listed as ‘ArticlePlus’ and can be found with the electronic version of this article on AdisOnline (http://​moleculardiagnos​istherapy.​adisonline.​com).
 
Literature
1.
go back to reference Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics: tumors of haematopoeitic and lymphoid tissues. World Health Organization classification of tumours. Lyon: International Agency for Research on Cancer, 2001 Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics: tumors of haematopoeitic and lymphoid tissues. World Health Organization classification of tumours. Lyon: International Agency for Research on Cancer, 2001
2.
go back to reference Gulley ML. Antigen receptor gene rearrangements. In: Leonard DGB, editor. Diagnostic molecular pathology: major problems in pathology. Vol. 41. Philadelphia (PA): Saunders, 2003: 118–24 Gulley ML. Antigen receptor gene rearrangements. In: Leonard DGB, editor. Diagnostic molecular pathology: major problems in pathology. Vol. 41. Philadelphia (PA): Saunders, 2003: 118–24
3.
go back to reference Pan L, Cesarman E, Knowles DM. Antigen receptor genes: structure, function and genetic analysis of their rearrangements. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia (PA): Williams and Wilkins, 2001: 307–28 Pan L, Cesarman E, Knowles DM. Antigen receptor genes: structure, function and genetic analysis of their rearrangements. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia (PA): Williams and Wilkins, 2001: 307–28
4.
go back to reference Antigen receptor genes and analysis of their rearrangements. In: Warnke RA, Weiss LM, Chan JKC, et al., editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology, 3rd series, fascicle 14. Washington DC: US Armed Forces Institute of Pathology, 1994: 31–4 Antigen receptor genes and analysis of their rearrangements. In: Warnke RA, Weiss LM, Chan JKC, et al., editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology, 3rd series, fascicle 14. Washington DC: US Armed Forces Institute of Pathology, 1994: 31–4
5.
go back to reference Evens AM, Gartenhaus RB. Treatment of T-cell non-Hodgkin’s lymphoma. Curr Treat Options Oncol 2004 Aug; 5(4): 289–303PubMedCrossRef Evens AM, Gartenhaus RB. Treatment of T-cell non-Hodgkin’s lymphoma. Curr Treat Options Oncol 2004 Aug; 5(4): 289–303PubMedCrossRef
6.
go back to reference Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004 Apr; 103(7): 2474–9PubMedCrossRef Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004 Apr; 103(7): 2474–9PubMedCrossRef
7.
go back to reference Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004 Oct; 15(10): 1467–75PubMedCrossRef Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004 Oct; 15(10): 1467–75PubMedCrossRef
8.
go back to reference Sehn LH, Connors JM. Treatment of aggressive non-Hodgkin’s lymphoma: a north American perspective. Oncology (Williston Park) 2005 Apr; 19(4 Suppl. 1): 26–34 Sehn LH, Connors JM. Treatment of aggressive non-Hodgkin’s lymphoma: a north American perspective. Oncology (Williston Park) 2005 Apr; 19(4 Suppl. 1): 26–34
9.
go back to reference Coiffier B, Reyes F. Groupe d’Etude des Lymphomes de l’Adulte. Best treatment of aggressive non-Hodgkin’s lymphoma: a French perspective. Oncology (Williston Park) 2005 Apr; 19(4 Suppl. 1): 7–15 Coiffier B, Reyes F. Groupe d’Etude des Lymphomes de l’Adulte. Best treatment of aggressive non-Hodgkin’s lymphoma: a French perspective. Oncology (Williston Park) 2005 Apr; 19(4 Suppl. 1): 7–15
10.
go back to reference Fisher RI, Miller TP, O’Connor OA. Diffuse aggressive lymphoma. Hematology (Am Soc Hematol Educ Program) 2004; 2004: 221–36CrossRef Fisher RI, Miller TP, O’Connor OA. Diffuse aggressive lymphoma. Hematology (Am Soc Hematol Educ Program) 2004; 2004: 221–36CrossRef
11.
go back to reference Younes A. New treatment strategies for aggressive lymphoma. Semin Oncol 2004 Dec; 31(6 Suppl. 15): 10–3PubMedCrossRef Younes A. New treatment strategies for aggressive lymphoma. Semin Oncol 2004 Dec; 31(6 Suppl. 15): 10–3PubMedCrossRef
12.
go back to reference Coiffier B. Effective immunochemotherapy for aggressive non-Hodgkin’s lymphoma. Semin Oncol 2004 Feb; 31(1 Suppl. 2): 7–11PubMedCrossRef Coiffier B. Effective immunochemotherapy for aggressive non-Hodgkin’s lymphoma. Semin Oncol 2004 Feb; 31(1 Suppl. 2): 7–11PubMedCrossRef
13.
go back to reference Kadin ME. Hodgkin’’s disease: cell of origin, immunobiology and pathogenesis. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia (PA): Williams and Wilkins, 2001: 667–90 Kadin ME. Hodgkin’’s disease: cell of origin, immunobiology and pathogenesis. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia (PA): Williams and Wilkins, 2001: 667–90
14.
go back to reference Hertel CB, Zhou XG, Hamilton-Dutoit SJ, et al. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2000; 21: 4908–20CrossRef Hertel CB, Zhou XG, Hamilton-Dutoit SJ, et al. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2000; 21: 4908–20CrossRef
15.
go back to reference Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443–50PubMed Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443–50PubMed
16.
go back to reference Theil J, Laumen H, Marafioti T, et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood 2001 May 15; 97(10): 3191–6PubMedCrossRef Theil J, Laumen H, Marafioti T, et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood 2001 May 15; 97(10): 3191–6PubMedCrossRef
17.
go back to reference Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84(5): 1361–92PubMed Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84(5): 1361–92PubMed
18.
go back to reference Jaffe ES. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol 2001; 14(3): 219–28PubMedCrossRef Jaffe ES. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol 2001; 14(3): 219–28PubMedCrossRef
19.
go back to reference Weisenburger DD, Anderson JR, Diebold J, et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin’s lymphoma classification project. Am J Hematol 2001; 67(3): 172–8PubMedCrossRef Weisenburger DD, Anderson JR, Diebold J, et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin’s lymphoma classification project. Am J Hematol 2001; 67(3): 172–8PubMedCrossRef
20.
go back to reference Tan LHC, Chong SM. Grade II nodular sclerosing Hodgkin lymphoma commonly mimics non-Hodgkin lymphomas with anaplastic morphology: a pathologic review of 42 cases reclassified by current WHO criteria [abstract]. Mod Pathol 2003 Jan; 16(1): 255A Tan LHC, Chong SM. Grade II nodular sclerosing Hodgkin lymphoma commonly mimics non-Hodgkin lymphomas with anaplastic morphology: a pathologic review of 42 cases reclassified by current WHO criteria [abstract]. Mod Pathol 2003 Jan; 16(1): 255A
21.
go back to reference Tan LHC, Do E, Tan SY, et al. Multi-lineage interrogation of the performance characteristics of a split-signal fluorescence in situ hybridization probe (FISH) for Anaplastic Lymphoma Kinase gene rearrangement: a study of 101 cases characterized by immunohistomorphology on fixed archival tissue. Mol Diagn 2004; 8(4): 213–29PubMedCrossRef Tan LHC, Do E, Tan SY, et al. Multi-lineage interrogation of the performance characteristics of a split-signal fluorescence in situ hybridization probe (FISH) for Anaplastic Lymphoma Kinase gene rearrangement: a study of 101 cases characterized by immunohistomorphology on fixed archival tissue. Mol Diagn 2004; 8(4): 213–29PubMedCrossRef
22.
go back to reference Tan LHC, Do E, Chong SM, et al. Detection of ALK gene rearrangements in formalin-fixed, paraffin-embedded tissue using a fluorescence in-situ hybridization (FISH) probe: a search for optimum conditions of tissue archiving and preparation for FISH. Mol Diagn 2003 Mar; 7(1): 27–33PubMedCrossRef Tan LHC, Do E, Chong SM, et al. Detection of ALK gene rearrangements in formalin-fixed, paraffin-embedded tissue using a fluorescence in-situ hybridization (FISH) probe: a search for optimum conditions of tissue archiving and preparation for FISH. Mol Diagn 2003 Mar; 7(1): 27–33PubMedCrossRef
23.
go back to reference Chang TL, Salto-Tellez M, Thamboo TP, et al. Diagnostic validation of capillary electrophoresis analysis of T-cell receptor γ-chain gene rearrangements: prediction of malignant transformation of cutaneous T-cell lymphoproliferative disorders. Clin Chemistry 2003; 49(3): 513–5CrossRef Chang TL, Salto-Tellez M, Thamboo TP, et al. Diagnostic validation of capillary electrophoresis analysis of T-cell receptor γ-chain gene rearrangements: prediction of malignant transformation of cutaneous T-cell lymphoproliferative disorders. Clin Chemistry 2003; 49(3): 513–5CrossRef
24.
go back to reference Sioutos N, Bagg A, Michaud GY, et al. Polymerase chain reaction versus Southern blot hybridization: detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol 1995 Mar; 4(1): 8–13PubMedCrossRef Sioutos N, Bagg A, Michaud GY, et al. Polymerase chain reaction versus Southern blot hybridization: detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol 1995 Mar; 4(1): 8–13PubMedCrossRef
25.
go back to reference McCarthy KP, Sloane JP, Kabarowski JHS, et al. The rapid detection of clonal T-cell proliferation in patients with lymphoid disorders. Am J Pathol 1991 Apr; 138(4): 821–8PubMed McCarthy KP, Sloane JP, Kabarowski JHS, et al. The rapid detection of clonal T-cell proliferation in patients with lymphoid disorders. Am J Pathol 1991 Apr; 138(4): 821–8PubMed
26.
go back to reference Classic Hodgkin’s disease. In: Warnke RA, Weiss LM, Chan JKC, et al., editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology, 3rd series, fascicle 14. Washington DC: US Armed Forces Institute of Pathology, 1994: 227–314 Classic Hodgkin’s disease. In: Warnke RA, Weiss LM, Chan JKC, et al., editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology, 3rd series, fascicle 14. Washington DC: US Armed Forces Institute of Pathology, 1994: 227–314
27.
go back to reference Achten R, Verhoef G, Vanuytsel L, et al. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 2002 Jan; 40(1): 31–45PubMedCrossRef Achten R, Verhoef G, Vanuytsel L, et al. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 2002 Jan; 40(1): 31–45PubMedCrossRef
28.
go back to reference Achten R, Verhoef G, Vanuytsel L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol 2002 Mar 1; 20(5): 1269–77PubMedCrossRef Achten R, Verhoef G, Vanuytsel L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol 2002 Mar 1; 20(5): 1269–77PubMedCrossRef
29.
go back to reference Lim MS, Beaty M, Sorbara L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 2002 Nov; 26(11): 1458–66PubMedCrossRef Lim MS, Beaty M, Sorbara L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 2002 Nov; 26(11): 1458–66PubMedCrossRef
30.
go back to reference Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988 Jun; 12(6): 433–43PubMedCrossRef Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988 Jun; 12(6): 433–43PubMedCrossRef
31.
go back to reference Lorenzen J, Li G, Zhao-Hohn M, et al. Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues. Virchows Arch 1994; 424(6): 593–600PubMedCrossRef Lorenzen J, Li G, Zhao-Hohn M, et al. Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues. Virchows Arch 1994; 424(6): 593–600PubMedCrossRef
32.
go back to reference Jones D, Jorgensen JL, Shahsafaei A, et al. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol 1998 Aug; 22(8): 956–64PubMedCrossRef Jones D, Jorgensen JL, Shahsafaei A, et al. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol 1998 Aug; 22(8): 956–64PubMedCrossRef
33.
go back to reference Lee S-S, Rudiger T, Odenwald T, et al. Angioimmunoblastic T-cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int J Cancer 2003; 103: 12–20PubMedCrossRef Lee S-S, Rudiger T, Odenwald T, et al. Angioimmunoblastic T-cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int J Cancer 2003; 103: 12–20PubMedCrossRef
34.
go back to reference Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99(2): 627–33PubMedCrossRef Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99(2): 627–33PubMedCrossRef
35.
go back to reference Kojima M, Nakamura S, Itoh H, et al. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: a clinicopathological and immunohistochemical study of 10 cases. APMIS 2001; 109: 699–706PubMedCrossRef Kojima M, Nakamura S, Itoh H, et al. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: a clinicopathological and immunohistochemical study of 10 cases. APMIS 2001; 109: 699–706PubMedCrossRef
36.
go back to reference Steinhoff M, Hummel M, Assaf C, et al. Cutaneous T cell lymphoma and classic Hodgkin lymphoma of B cell type within a single lymph node: composite lymphoma. J Clin Pathol 2004 Mar; 57(3): 329–31PubMedCrossRef Steinhoff M, Hummel M, Assaf C, et al. Cutaneous T cell lymphoma and classic Hodgkin lymphoma of B cell type within a single lymph node: composite lymphoma. J Clin Pathol 2004 Mar; 57(3): 329–31PubMedCrossRef
37.
go back to reference Quintanilla-Martinez L, Fend F, Moguel LR, et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 1999; 23(10): 1233–40PubMedCrossRef Quintanilla-Martinez L, Fend F, Moguel LR, et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 1999; 23(10): 1233–40PubMedCrossRef
38.
go back to reference Higgins JP, van de Rijn M, Jones CD, et al. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol 2000; 114(2): 236–47PubMedCrossRef Higgins JP, van de Rijn M, Jones CD, et al. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol 2000; 114(2): 236–47PubMedCrossRef
39.
go back to reference Schwarting R, Gerdes J, Durkop H, et al. Ber-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989 Oct; 74(5): 1678–89PubMed Schwarting R, Gerdes J, Durkop H, et al. Ber-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989 Oct; 74(5): 1678–89PubMed
40.
go back to reference Piris M, Brown DC, Gatter KC, et al. CD30 expression in non-Hodgkin’s lymphoma. Histopathology 1990 Sep; 17(3): 211–8PubMedCrossRef Piris M, Brown DC, Gatter KC, et al. CD30 expression in non-Hodgkin’s lymphoma. Histopathology 1990 Sep; 17(3): 211–8PubMedCrossRef
41.
go back to reference Lukes RL, Tindle BH. Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 1975 Jan 2; 292(1): 1–8PubMedCrossRef Lukes RL, Tindle BH. Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 1975 Jan 2; 292(1): 1–8PubMedCrossRef
42.
go back to reference Knecht H, Berger C, Rothenberger S, et al. The role of Epstein-Barr virus in neoplastic transformation. Oncology 2001; 60: 289–302PubMedCrossRef Knecht H, Berger C, Rothenberger S, et al. The role of Epstein-Barr virus in neoplastic transformation. Oncology 2001; 60: 289–302PubMedCrossRef
43.
go back to reference Lome-Maldonado C, Canioni D, Hermine O, et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection: a different subtype of AILD-TL? Leukemia 2002; 16: 2134–41PubMedCrossRef Lome-Maldonado C, Canioni D, Hermine O, et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection: a different subtype of AILD-TL? Leukemia 2002; 16: 2134–41PubMedCrossRef
44.
go back to reference Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002; 117(3): 368–79PubMedCrossRef Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002; 117(3): 368–79PubMedCrossRef
45.
go back to reference Ho JWY, Ho FSC, Chan ACL, et al. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol 1998; 185: 79–85PubMedCrossRef Ho JWY, Ho FSC, Chan ACL, et al. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol 1998; 185: 79–85PubMedCrossRef
46.
go back to reference Nakamura S, Sasajima Y, Koshikawa T, et al. Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin’s disease associated with Epstein-Barr virus. Pathol Int 1995; 45(120): 958–64PubMedCrossRef Nakamura S, Sasajima Y, Koshikawa T, et al. Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin’s disease associated with Epstein-Barr virus. Pathol Int 1995; 45(120): 958–64PubMedCrossRef
47.
go back to reference Willenbrock K, Roes A, Seidl C, et al. Analysis of T-cell subpopulations in T-cell non-Hodgkin’s lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-β gene rearrangements. Am J Pathol 2001; 158(5): 1851–7PubMedCrossRef Willenbrock K, Roes A, Seidl C, et al. Analysis of T-cell subpopulations in T-cell non-Hodgkin’s lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-β gene rearrangements. Am J Pathol 2001; 158(5): 1851–7PubMedCrossRef
48.
go back to reference Smith JL, Hodges E, Quin CT, et al. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000 Feb; 156(2): 661–9PubMedCrossRef Smith JL, Hodges E, Quin CT, et al. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000 Feb; 156(2): 661–9PubMedCrossRef
49.
go back to reference Diss TC, Watts M, Pan LX, et al. The polymerase chain reaction in the detection of monoclonality in T-cell lymphomas. J Clin Pathol 1995; 48: 1045–50PubMedCrossRef Diss TC, Watts M, Pan LX, et al. The polymerase chain reaction in the detection of monoclonality in T-cell lymphomas. J Clin Pathol 1995; 48: 1045–50PubMedCrossRef
50.
go back to reference Polliack A, Lugassy G. Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia 1992; 6Suppl. 4: 152–4PubMed Polliack A, Lugassy G. Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia 1992; 6Suppl. 4: 152–4PubMed
51.
go back to reference Pavlidis NA, Klouvas G, Tsokos M, et al. Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders: a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma 1995; 16(5-6): 477–82PubMedCrossRef Pavlidis NA, Klouvas G, Tsokos M, et al. Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders: a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma 1995; 16(5-6): 477–82PubMedCrossRef
52.
go back to reference Yataganas X, Papadimitriou C, Pangalis G, et al. Angio-immunoblastic lymphadenopathy terminating as Hodgkin’s disease. Cancer 1977 May; 39(5): 2183–9PubMedCrossRef Yataganas X, Papadimitriou C, Pangalis G, et al. Angio-immunoblastic lymphadenopathy terminating as Hodgkin’s disease. Cancer 1977 May; 39(5): 2183–9PubMedCrossRef
53.
go back to reference Diss TC, Peng H, Wotherspoon AC, et al. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 1993 Mar; 169(3): 291–5PubMedCrossRef Diss TC, Peng H, Wotherspoon AC, et al. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 1993 Mar; 169(3): 291–5PubMedCrossRef
54.
go back to reference Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene variable region of 101 cases with peripheral B cell neoplasms and B cell chronic lymphocytic leukemia in the Japanese population. Pathol Int 1999 Jul; 49(7): 595–600PubMedCrossRef Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene variable region of 101 cases with peripheral B cell neoplasms and B cell chronic lymphocytic leukemia in the Japanese population. Pathol Int 1999 Jul; 49(7): 595–600PubMedCrossRef
55.
go back to reference Stein H, Foss HD, Durkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000 Dec 1; 96(12): 3681–95PubMed Stein H, Foss HD, Durkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000 Dec 1; 96(12): 3681–95PubMed
56.
go back to reference Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin’s disease provides further evidence for its B-cell origin. Blood 1999 Nov 1; 94(9): 3108–13PubMed Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin’s disease provides further evidence for its B-cell origin. Blood 1999 Nov 1; 94(9): 3108–13PubMed
57.
go back to reference Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997 Mar 1; 89(5): 1483–90PubMed Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997 Mar 1; 89(5): 1483–90PubMed
58.
go back to reference Gascoyne RD, Lamant L, Martin-Suberto JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003 Oct; 102(7): 2568–73PubMedCrossRef Gascoyne RD, Lamant L, Martin-Suberto JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003 Oct; 102(7): 2568–73PubMedCrossRef
59.
go back to reference De Paepe P, Baens M, van Krieken H, et al. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 2003 Oct; 102(7): 2638–41PubMedCrossRef De Paepe P, Baens M, van Krieken H, et al. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 2003 Oct; 102(7): 2638–41PubMedCrossRef
60.
go back to reference Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003 Oct; 102(7): 2642–4PubMedCrossRef Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003 Oct; 102(7): 2642–4PubMedCrossRef
61.
go back to reference Falini B, Pulford K, Pucciarini A, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999 Nov 15; 94(10): 3509–15PubMed Falini B, Pulford K, Pucciarini A, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999 Nov 15; 94(10): 3509–15PubMed
62.
go back to reference Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997 Feb; 89(4): 1394–404PubMed Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997 Feb; 89(4): 1394–404PubMed
63.
go back to reference Tan LHC. ALK-positive anaplastic T-cell lymphoma, combined small-cell/ lymphohistiocytic variant, mimicking Kikuchi-Fujimoto (subacute/histiocytic necrotizing) lymphadenitis. In: Cooke RA, editor. Surgical pathology: a Singapore-Malaysia experience. Slide seminar, XXV Congress of the International Academy of Pathology; 2004 Oct 11–16; Brisbane. Brisbane: Knowledge Books and Software, 2004: 79–89 Tan LHC. ALK-positive anaplastic T-cell lymphoma, combined small-cell/ lymphohistiocytic variant, mimicking Kikuchi-Fujimoto (subacute/histiocytic necrotizing) lymphadenitis. In: Cooke RA, editor. Surgical pathology: a Singapore-Malaysia experience. Slide seminar, XXV Congress of the International Academy of Pathology; 2004 Oct 11–16; Brisbane. Brisbane: Knowledge Books and Software, 2004: 79–89
64.
go back to reference Beaubier NT, Hart AP, Bartolo C, et al. Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction. Diagn Mol Pathol 2000; 9(3): 121–31PubMedCrossRef Beaubier NT, Hart AP, Bartolo C, et al. Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction. Diagn Mol Pathol 2000; 9(3): 121–31PubMedCrossRef
65.
go back to reference Sprouse J, Werling R, Hanke D, et al. T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gammachain gene and capillary electrophoresis of fluorescently-labelled products. Am J Clin Pathol 2000; 113: 838–50PubMedCrossRef Sprouse J, Werling R, Hanke D, et al. T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gammachain gene and capillary electrophoresis of fluorescently-labelled products. Am J Clin Pathol 2000; 113: 838–50PubMedCrossRef
66.
go back to reference Simon M, Kind P, Kaudewitz P, et al. Automated high-resolution polymerase chain reaction fragment analysis. A method for detecting T-cell receptor gammachain gene rearrangements in lymphoproliferative diseases. Am J Pathol 1998; 152(1): 29–33PubMed Simon M, Kind P, Kaudewitz P, et al. Automated high-resolution polymerase chain reaction fragment analysis. A method for detecting T-cell receptor gammachain gene rearrangements in lymphoproliferative diseases. Am J Pathol 1998; 152(1): 29–33PubMed
67.
go back to reference Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998 Mar 15; 91(6): 2076–84PubMed Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998 Mar 15; 91(6): 2076–84PubMed
68.
go back to reference Tan LHC, Chen CS, Mow BMF, et al. Medullary myeloid disorders in young patients negate large-cell lymphoma and favor extramedullary myeloblastic tumor/granulocytic sarcoma. Proceedings of the 4th Asia-Pacific International Academy of Pathology Congress; 2005 Aug 23–26; Beijing. Bologna: Medimond International Proceedings, 2005: 119–23 Tan LHC, Chen CS, Mow BMF, et al. Medullary myeloid disorders in young patients negate large-cell lymphoma and favor extramedullary myeloblastic tumor/granulocytic sarcoma. Proceedings of the 4th Asia-Pacific International Academy of Pathology Congress; 2005 Aug 23–26; Beijing. Bologna: Medimond International Proceedings, 2005: 119–23
69.
go back to reference Sanchez I, San Miguel JF, Corral J, et al. Gene rearrangement in acute non-lymphoblastic leukaemia: correlation with morphological and immunophenotypic characteristics of blast cells. Br J Haematol 1995 Jan; 89(1): 104–9PubMedCrossRef Sanchez I, San Miguel JF, Corral J, et al. Gene rearrangement in acute non-lymphoblastic leukaemia: correlation with morphological and immunophenotypic characteristics of blast cells. Br J Haematol 1995 Jan; 89(1): 104–9PubMedCrossRef
70.
go back to reference Paietta E, Van Ness B, Bennett J, et al. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations. Br J Haematol 1992 Oct; 82(2): 324–31PubMedCrossRef Paietta E, Van Ness B, Bennett J, et al. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations. Br J Haematol 1992 Oct; 82(2): 324–31PubMedCrossRef
71.
go back to reference Rudiger T, Jaffe ES, Delsol G, et al. Workshop report on Hodgkin’s disease and related diseases (‘grey zone’ lymphoma). Ann Oncol 1998; 9Suppl. 5: S31–8PubMedCrossRef Rudiger T, Jaffe ES, Delsol G, et al. Workshop report on Hodgkin’s disease and related diseases (‘grey zone’ lymphoma). Ann Oncol 1998; 9Suppl. 5: S31–8PubMedCrossRef
72.
go back to reference Mohrmann RL, Arber DA. CD20-positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin’ s disease and review of the literature. Mod Pathol 2000 Nov; 13(11): 1244–52PubMedCrossRef Mohrmann RL, Arber DA. CD20-positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin’ s disease and review of the literature. Mod Pathol 2000 Nov; 13(11): 1244–52PubMedCrossRef
73.
go back to reference Hodges E, Krishna MT, Pickard C, et al. Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 2003; 56: 1–11PubMedCrossRef Hodges E, Krishna MT, Pickard C, et al. Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 2003; 56: 1–11PubMedCrossRef
74.
go back to reference Ye MQ, Suriawinata A, Black C, et al. Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch Pathol Lab Med 2000 Apr; 124(4): 604–8PubMed Ye MQ, Suriawinata A, Black C, et al. Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch Pathol Lab Med 2000 Apr; 124(4): 604–8PubMed
75.
go back to reference Prabhu RM, Medeiros LJ, Kumar D, et al. Primary hepatic low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis. Mod Pathol 1998 Apr; 11(4): 404–10PubMed Prabhu RM, Medeiros LJ, Kumar D, et al. Primary hepatic low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis. Mod Pathol 1998 Apr; 11(4): 404–10PubMed
76.
go back to reference Stroehmann A, Dorner T, Lukowsky A, et al. Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjogren’s syndrome. J Rheumatol 2002 Jun; 29(6): 1326–9PubMed Stroehmann A, Dorner T, Lukowsky A, et al. Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjogren’s syndrome. J Rheumatol 2002 Jun; 29(6): 1326–9PubMed
77.
go back to reference Childs CC, Parham DM, Berard CW. Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils. Am J Surg Pathol 1987 Feb; 11(2): 122–32PubMedCrossRef Childs CC, Parham DM, Berard CW. Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils. Am J Surg Pathol 1987 Feb; 11(2): 122–32PubMedCrossRef
78.
go back to reference Tindle BH, Parker JW, Lukes RJ. “Reed-Sternberg cells” in infectious mononucleosis? Am J Clin Pathol 1972 Dec; 58(6): 607–17PubMed Tindle BH, Parker JW, Lukes RJ. “Reed-Sternberg cells” in infectious mononucleosis? Am J Clin Pathol 1972 Dec; 58(6): 607–17PubMed
79.
go back to reference Lukes RJ. Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin’s disease. Cancer Res 1971 Nov; 31(11): 1755–67PubMed Lukes RJ. Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin’s disease. Cancer Res 1971 Nov; 31(11): 1755–67PubMed
80.
go back to reference Kadin ME, Glatstein E, Dorfman RF. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin’s disease. Cancer 1971 Jun; 27(6): 1277–94PubMedCrossRef Kadin ME, Glatstein E, Dorfman RF. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin’s disease. Cancer 1971 Jun; 27(6): 1277–94PubMedCrossRef
81.
go back to reference Van Parys G, de Wolf-Peeters C, van den Oord JJ, et al. Lymph node architecture in Hodgkin’s disease: evidence for the role of the composite nodule in nodular sclerosing Hodgkin’s disease. Hematol Oncol 1987 Apr–Jun; 5(2): 147–54PubMedCrossRef Van Parys G, de Wolf-Peeters C, van den Oord JJ, et al. Lymph node architecture in Hodgkin’s disease: evidence for the role of the composite nodule in nodular sclerosing Hodgkin’s disease. Hematol Oncol 1987 Apr–Jun; 5(2): 147–54PubMedCrossRef
82.
go back to reference Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000 Sep 1; 96(5): 1889–99PubMed Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000 Sep 1; 96(5): 1889–99PubMed
83.
go back to reference Cabone A, Gloghini A, Gaidano G, et al. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin’s disease. Blood 1998 Oct 1; 92(7): 2220–8 Cabone A, Gloghini A, Gaidano G, et al. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin’s disease. Blood 1998 Oct 1; 92(7): 2220–8
84.
go back to reference Carbone A, Gloghini A, Aldinucci D, et al. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. Br J Haematol 2002 May; 117(2): 366–72PubMedCrossRef Carbone A, Gloghini A, Aldinucci D, et al. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. Br J Haematol 2002 May; 117(2): 366–72PubMedCrossRef
85.
go back to reference Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002 Jun 15; 99(12): 4283–97PubMedCrossRef Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002 Jun 15; 99(12): 4283–97PubMedCrossRef
86.
go back to reference Tsang WY, Chan JK, Sing C. The nature of Reed-Sternberg-like cells in chronic lymphocytic leukemia. Am J Clin Pathol 1993 Mar; 99(3): 317–23PubMed Tsang WY, Chan JK, Sing C. The nature of Reed-Sternberg-like cells in chronic lymphocytic leukemia. Am J Clin Pathol 1993 Mar; 99(3): 317–23PubMed
87.
go back to reference Roers A, Montesinos-Rongen M, Hansmann ML, et al. Amplification of TCRbeta gene rearrangements from micromanipulated single cells: T cells rosetting around Hodgkin and Reed-Sternberg cells in Hodgkin’s disease are polyclonal. Eur J Immunol 1998 Aug; 28(8): 2424–31PubMedCrossRef Roers A, Montesinos-Rongen M, Hansmann ML, et al. Amplification of TCRbeta gene rearrangements from micromanipulated single cells: T cells rosetting around Hodgkin and Reed-Sternberg cells in Hodgkin’s disease are polyclonal. Eur J Immunol 1998 Aug; 28(8): 2424–31PubMedCrossRef
88.
go back to reference Poppema S, Potters M, Visser L, et al. Immune escape mechanisms in Hodgkin’s disease. Ann Oncol 1998; 9Suppl. 5: S21–4PubMedCrossRef Poppema S, Potters M, Visser L, et al. Immune escape mechanisms in Hodgkin’s disease. Ann Oncol 1998; 9Suppl. 5: S21–4PubMedCrossRef
89.
go back to reference Cazals-Hatem D, Andre M, Mounier N, et al. Pathologic and clinical features of 77 Hodgkin’s lymphoma patients treated in a lymphoma protocol (LNH87). Am J Surg Pathol 2001 Mar; 25(3): 297–306PubMedCrossRef Cazals-Hatem D, Andre M, Mounier N, et al. Pathologic and clinical features of 77 Hodgkin’s lymphoma patients treated in a lymphoma protocol (LNH87). Am J Surg Pathol 2001 Mar; 25(3): 297–306PubMedCrossRef
90.
go back to reference Brousset P, Rochaix P, Chittal S, et al. High incidence of Epstein-Barr virus detection in Hodgkin’s disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993 Aug; 23(2): 189–91PubMedCrossRef Brousset P, Rochaix P, Chittal S, et al. High incidence of Epstein-Barr virus detection in Hodgkin’s disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993 Aug; 23(2): 189–91PubMedCrossRef
91.
go back to reference Calame C, Lin K-I, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003; 21: 205–30PubMedCrossRef Calame C, Lin K-I, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003; 21: 205–30PubMedCrossRef
92.
go back to reference Dong HY, Scadden DT, de Levai L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005 Dec; 29(12): 1633–41PubMedCrossRef Dong HY, Scadden DT, de Levai L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005 Dec; 29(12): 1633–41PubMedCrossRef
93.
go back to reference Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005 Jun; 18(6): 806–15PubMedCrossRef Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005 Jun; 18(6): 806–15PubMedCrossRef
94.
go back to reference Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004 Jun; 28(6): 736–47PubMedCrossRef Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004 Jun; 28(6): 736–47PubMedCrossRef
95.
go back to reference Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. London: Prentice-Hall, 1994: 143–61 Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. London: Prentice-Hall, 1994: 143–61
96.
go back to reference Seow A, Koh WP, Chia KS, et al. Trends in cancer incidence in Singapore 1968-2002. Report No. 6. Singapore: Singapore Cancer Registry, 2004 Seow A, Koh WP, Chia KS, et al. Trends in cancer incidence in Singapore 1968-2002. Report No. 6. Singapore: Singapore Cancer Registry, 2004
Metadata
Title
Diagnostic Impact of Molecular Lineage Analysis on Paraffin-Embedded Tissue in Hematolymphoid Neoplasia Reclassified by Current WHO Criteria
Authors
Leonard Hwan Cheong Tan
Lily-Lily Chiu
Evelyn Siew Chuan Koay
Publication date
01-01-2007
Publisher
Springer International Publishing
Published in
Molecular Diagnosis & Therapy / Issue 1/2007
Print ISSN: 1177-1062
Electronic ISSN: 1179-2000
DOI
https://doi.org/10.1007/BF03256221

Other articles of this Issue 1/2007

Molecular Diagnosis & Therapy 1/2007 Go to the issue

Original Research Article

Retinoblastoma in India

Technical Resource

The BiolAD-DB System

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.